Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...

For people living with Type 1 Diabetes, keeping blood sugar levels in check is a constant challenge. A new clinical trial at ...

The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...

As Basaglar is an injectable insulin that a person does not use with an insulin pump, it may be available ... individuals will already have lower insulin cost sharing and will continue to pay ...

For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to ...

There’s an ongoing push to improve health care affordability and reduce out-of-pocket costs, especially for prescription ...

Adjusted EBITDA margin increased to 37.2% from 25.2% in Q4 2024, driven by cost reductions and operational improvements. Management's tone shifted positively, highlighting stronger-than-expected ...

Sam King's 9-year-old son was diagnosed with Type 1 diabetes.King, who is now an associate professor of computer science at ...

Three companies that are better positioned to withstand Trump's tariff challenges are ResMed, Hims & Hers Health and Medtronic.

The company estimates that its install base surpassed 15,000 by the end of last year, leading to sales of more than $20 million in the fourth quarter.

Beta Bionics’ IPO marks one of the largest public offerings for an Orange County-based company in over three years, second ...